SPY363.67+1.01 0.28%
DIA299.24+0.50 0.17%
IXIC12,205.85+111.44 0.92%

Goldman Sachs Reinstates Neutral on Pfizer, Announces $40 Price Target

Goldman Sachs analyst Terence Flynn reinstates Pfizer (NYSE:PFE) with a Neutral and announces $40 price target.

· 11/19/2020 08:20
Goldman Sachs analyst Terence Flynn reinstates Pfizer (NYSE:PFE) with a Neutral and announces $40 price target.